219 related articles for article (PubMed ID: 20805699)
1. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy.
Kim S; Chin HJ; Na KY; Kim S; Oh J; Chung W; Noh JW; Lee YK; Cho JT; Lee EK; Chae DW;
Nephron Clin Pract; 2011; 117(3):c253-8. PubMed ID: 20805699
[TBL] [Abstract][Full Text] [Related]
2. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
Liu X; Xu W; Yu C; Wang M; Liu R; Xie R
Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530
[TBL] [Abstract][Full Text] [Related]
3. [Association of single nucleotide polymorphism in M-type phospholipase A2 receptor gene with membranous nephropathy].
Zhou GY; Liu F; Zhang WL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):706-10. PubMed ID: 24327152
[TBL] [Abstract][Full Text] [Related]
4. Association of SNPs in
Tian CX; Li L; Qiu P; Qiu YR
Br J Biomed Sci; 2020 Jan; 77(1):24-28. PubMed ID: 31532353
[No Abstract] [Full Text] [Related]
5. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
6. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis.
Yoshikawa M; Asaba K
Sci Rep; 2020 Aug; 10(1):13119. PubMed ID: 32753608
[TBL] [Abstract][Full Text] [Related]
8. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
10. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
[TBL] [Abstract][Full Text] [Related]
11. PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes.
Saeed M; Beggs ML; Walker PD; Larsen CP
Genes Immun; 2014 Dec; 15(8):556-61. PubMed ID: 25187357
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase A
Si NV; Fujioka D; Watanabe K; Watanabe Y; Watanabe K; Nakamura K; Yamaguchi K; Uematsu M; Kugiyama K
J Atheroscler Thromb; 2016 Oct; 23(10):1227-1241. PubMed ID: 27025682
[TBL] [Abstract][Full Text] [Related]
13. Clinical Predictive Value of Phospholipase A2 Receptor Gene Polymorphism Combined with Subclass of Immunoglobulin G in Renal Tissues for Membranous Nephropathy.
Ji C; Xu Q; Bian X
Altern Ther Health Med; 2023 Oct; 29(7):418-423. PubMed ID: 37535917
[TBL] [Abstract][Full Text] [Related]
14. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan.
Liu YH; Chen CH; Chen SY; Lin YJ; Liao WL; Tsai CH; Wan L; Tsai FJ
J Biomed Sci; 2010 Oct; 17(1):81. PubMed ID: 20937089
[TBL] [Abstract][Full Text] [Related]
15. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
[TBL] [Abstract][Full Text] [Related]
16. Recent advances and prognosis in idiopathic membranous nephropathy.
Segal PE; Choi MJ
Adv Chronic Kidney Dis; 2012 Mar; 19(2):114-9. PubMed ID: 22449349
[TBL] [Abstract][Full Text] [Related]
17. Variants in the Promoter Region of
Qin XS; Liu JH; Lyu GT; Peng ML; Yang FN; Qin DC; Li YZ; Liu Y
Chin Med J (Engl); 2017 Jul; 130(14):1677-1682. PubMed ID: 28685717
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.
Hayashi N; Akiyama S; Okuyama H; Matsui Y; Adachi H; Yamaya H; Maruyama S; Imai E; Matsuo S; Yokoyama H
Clin Exp Nephrol; 2015 Oct; 19(5):797-803. PubMed ID: 25492250
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
[TBL] [Abstract][Full Text] [Related]
20. Interaction between PLA2R1 and HLA-DQA1 variants contributes to the increased genetic susceptibility to membranous nephropathy in Western China.
Wang W; Fan S; Li G; Wang AY; Hong D; Zhong X; Wang L
Nephrology (Carlton); 2019 Sep; 24(9):919-925. PubMed ID: 30467913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
